Sildenafil for the Prevention of Right Heart Failure Following Continuous-Flow Left Ventricular Assist Device Implantation (The REVAD Study)
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Sildenafil (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms The REVAD Study
- 27 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 1 Mar 2018.
- 05 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Jan 2018.
- 01 Dec 2017 New trial record